UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2024

 

Commission File Number:  001-41324

 

AKANDA CORP.

(Name of registrant)

 

1a, 1b Learoyd Road 

New Romney TN28 8XU, United Kingdom 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

  x     Form 20-F ¨     Form 40-F  

 

 

 

 

EXHIBIT INDEX

 

On May 16, 2024, Akanda Corp. (the “Company”) issued a press release titled “Akanda Corp. Receives Notice Of Non-Compliance From Nasdaq”, a copy of which is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.

The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section.

 

Exhibit No.

 

Description

   
99.1 Press Release, dated May 16, 2024.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AKANDA CORP.
  (Registrant)
     
Date:  May 16, 2024 By: /s/ Katie Field
    Name: Katie Field
    Title:

Interim Chief Executive Officer

and Director

 

 

 

 

 

Exhibit 99.1

 

AKANDA CORP. RECEIVES NOTICE OF NON-COMPLIANCE FROM NASDAQ

London, UK May 16, 2024 –Akanda Corp. ("Akanda" or the “Company”)  (NASDAQ: AKAN), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).

According to Nasdaq’s listing requirements, companies must maintain a minimum stockholders' equity of $2,500,000. As reported in Akanda’s Form 20-F for the fiscal year ended December 31, 2023, the Company's stockholders’ equity was reported as ($3,828,892). Akanda currently does not meet the alternative compliance standards based on market value of listed securities or net income from continuing operations.

Under Nasdaq rules, Akanda has 45 calendar days, or until June 28, 2024, to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Akanda may be granted an extension of up to 180 days from the date of the notification letter to evidence compliance.

Akanda is currently evaluating its options to resolve the deficiency and intends to submit a comprehensive plan to regain compliance within the stipulated timeframe. The Company will provide updates on its progress as appropriate.

This announcement does not impact Akanda’s listing on Nasdaq at this time, and its common shares will continue to trade on the Nasdaq Capital Market under the symbol "AKAN".

Katie Field, Interim Chief Executive Officer of Akanda, commented, “We are taking immediate steps to address this matter and are focused on actions that will lead to regaining compliance with Nasdaq’s listing requirements. We appreciate the continued support of our investors during this period.”

This disclosure is being made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt public disclosure of receipt of a deficiency notification.

About Akanda Corp.

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

Investor Contact

ir@akandacorp.com

Cautionary Note Regarding Forward-Looking Information and Statements

 

This press release contains certain "forward-looking information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved" and similar expressions and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

 

 

 


Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Akanda Charts.
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Akanda Charts.